衞星化學(002648.SZ):α-烯烴綜合利用高端產業園項目一階段的6艘VLEC乙烷船已經在2023年7月下單建造,預計會在2026年初交付
格隆匯10月23日丨衞星化學(002648.SZ)於2024年10月22日召開電話會議,就“公司α-烯烴綜合利用高端新材料產業園項目配套的乙烷船預定情況?”,公司表示,公司α-烯烴綜合利用高端產業園項目一階段的6艘VLEC乙烷船已經在2023年7月下單建造,預計會在2026年初交付,與公司項目一階段建設進度保持一致。二階段的8艘ULEC乙烷運輸船已經分兩批於2024年8月和10月下單建造,會配套滿足項目二階段裝置投產運行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.